What Is True Of Fitzpatrick Skin Types 5 And 6

Fitzpatrick skin types 5 and 6 represent the darkest categories on the six-point scale used to classify skin by its response to ultraviolet light. Type 5 skin is dark brown, rarely or never burns, and always tans. Type 6 skin is deeply pigmented black skin that never burns and always tans. Both types share higher baseline melanin production, larger pigment-carrying structures in the skin, and more reactive pigment-producing cells, which together create a set of distinct strengths and vulnerabilities worth understanding.

How the Scale Classifies Types 5 and 6

The Fitzpatrick scale was originally created in 1975 with only four categories, all describing white skin. Types 5 and 6 were added in 1988 to account for darker skin tones. The original intent was to place all Black individuals into type 6, but the scale evolved to recognize the wide biological range within darker skin. Type 5 generally includes people of South Asian, Middle Eastern, and some Latin American and African descent, while type 6 most often describes people of sub-Saharan African and Melanesian backgrounds.

The core difference between these types and lighter ones comes down to melanin. Skin types 5 and 6 have significantly more melanin in the outer layer of skin, and that melanin is packaged in larger, more widely distributed structures called melanosomes. This isn’t just a cosmetic difference. It changes how the skin interacts with sunlight, heals from injury, and presents signs of disease.

Built-In UV Protection and Its Limits

The high melanin content in types 5 and 6 acts as a natural UV filter. Research estimates that deeply pigmented Black skin filters out roughly five times as much UV radiation as light Caucasian skin, providing an intrinsic sun protection factor (SPF) of about 13.4, compared to around 3.3 for light skin. That’s meaningful protection, but it’s not immunity. Within “Black skin” alone, there is a wide range of actual pigmentation, so any single SPF estimate is an approximation.

This natural shielding dramatically reduces the risk of the most common UV-driven skin cancers. But it can also create a false sense of security. Skin cancers that do occur in types 5 and 6 tend to be diagnosed later, partly because both patients and clinicians may not be looking for them. The most relevant type is acral lentiginous melanoma, a rare subtype that appears on the palms, soles, and under the nails rather than on sun-exposed areas. It accounts for only about 5% of all melanomas overall, but it is the most commonly diagnosed melanoma subtype in non-Caucasian patients. Plantar melanomas (on the soles of the feet), the most common site in darker-skinned individuals, are often caught late and carry a worse prognosis.

Vitamin D Production Is Slower

Melanin’s UV-filtering ability comes with a trade-off: it slows the skin’s ability to produce vitamin D from sunlight. This is a well-established concern for people with types 5 and 6 skin, particularly those living at higher latitudes with less intense sunlight. Even in tropical regions with abundant sun exposure, vitamin D deficiency remains surprisingly common. One study of people living in the tropics with high daily sun exposure found that 31% were deficient in vitamin D and over 63% had insufficient levels, suggesting that sun exposure alone is often not enough to maintain adequate vitamin D regardless of skin type. For types 5 and 6, the barrier is even higher because melanin competes with the skin cells that initiate vitamin D synthesis for the same UV photons.

How Inflammation Looks Different

One of the most clinically significant truths about types 5 and 6 is that redness, the classic sign of inflammation, often doesn’t look red. In deeply pigmented skin, what would appear as bright red irritation on lighter skin may instead show up as violaceous (purplish), gray, or dark brown discoloration. This applies to conditions like eczema, where inflamed patches can be subtle and easily missed.

This isn’t a minor cosmetic detail. Many diagnostic tools and clinical training materials were built around how disease looks on lighter skin. When a clinician is searching for “redness” on type 6 skin, they may underestimate or entirely miss active inflammation. This has real consequences for timely diagnosis and treatment of conditions ranging from eczema to cellulitis to drug reactions.

Post-Inflammatory Hyperpigmentation

After any skin injury or inflammation, from acne to a bug bite to a cosmetic procedure, types 5 and 6 are significantly more likely to develop post-inflammatory hyperpigmentation (PIH). This happens because the melanocytes in darker skin are more reactive. When triggered by inflammation, they overproduce melanin or deposit it irregularly, leaving dark marks that can far outlast the original problem.

The darker the skin, the more intense and persistent these marks tend to be. While PIH does generally improve on its own, the timeline can stretch from months to years. For many people with types 5 and 6 skin, the dark spots left behind by acne are more distressing than the acne itself, and treating them requires patience and gentle approaches, since aggressive treatments can trigger yet more pigmentation.

Higher Risk of Abnormal Scarring

Keloid and hypertrophic scars form when the body overproduces collagen during wound healing. People with types 5 and 6 skin have a well-documented genetic predisposition to this kind of scarring, with the highest prevalence in people of African descent, followed by Asian and Hispanic populations. Keloids produce roughly 20 times more collagen than normal scars, creating raised, firm tissue that can extend well beyond the original wound.

The underlying mechanism involves an imbalance in the inflammatory signals that regulate how fibroblasts (the cells that build scar tissue) behave during healing. Overactive pro-inflammatory signaling paired with reduced anti-inflammatory signaling pushes collagen production into overdrive. This is why even minor skin trauma, including ear piercings, surgical incisions, or vaccinations, can produce prominent keloids in susceptible individuals. For people who know they scar this way, this risk factor influences decisions about elective procedures and wound care strategies.

Dermatosis Papulosa Nigra

Dermatosis papulosa nigra (DPN) is a benign skin condition that disproportionately affects people with darker skin types. These are small, dark, raised papules that typically appear on the face and neck, ranging from 1 to 5 millimeters. Incidence rates run as high as 70% in African Americans and about 40% in African populations. There is a strong genetic component: 84% of people with DPN in one study reported a first-degree relative with the same condition.

The average person with DPN has around 23 lesions, though counts range widely from 4 to over 70. Most appear on the face, followed by the neck and chest. The lesions have no malignant potential and are harmless, but they are one of the most common reasons people with types 5 and 6 skin seek cosmetic dermatology. Recent research has identified mutations in a growth factor receptor in DPN lesions similar to those found in seborrheic keratoses, a common benign growth in older adults of all skin types.

Laser and Light-Based Treatments

Cosmetic and medical procedures that use lasers or intense light carry specific risks for types 5 and 6 skin. The problem is straightforward: lasers work by targeting pigment, and when there is abundant melanin throughout the skin’s outer layer, the laser energy gets absorbed by the skin itself rather than reaching its intended target, whether that’s a hair follicle, a tattoo, or a blood vessel. This can cause burns, blistering, and paradoxically, more hyperpigmentation.

The workaround is using lasers with longer wavelengths, particularly the 1,064-nanometer wavelength. At this wavelength, melanin absorbs less energy, allowing the light to penetrate deeper and reach its target while sparing the pigmented outer layer. This is why many dermatologists use this specific laser type for hair removal and other procedures in patients with Fitzpatrick types 4 through 6. The results can be effective and safe, but the margin for error is narrower, and the practitioner’s experience with darker skin tones matters considerably.